F. Izadyar et al., IN-VITRO MATURATION OF BOVINE OOCYTES IN THE PRESENCE OF GROWTH-HORMONE ACCELERATES NUCLEAR MATURATION AND PROMOTES SUBSEQUENT EMBRYONIC-DEVELOPMENT, Molecular reproduction and development, 45(3), 1996, pp. 372-377
Regulatory effect of GH on follicular growth and development in the co
w is well documented. The aim of this study was to investigate the rol
e of GH on in vitro bovine oocyte maturation. Therefore bovine cumulus
oocyte complexes (COCs) were cultured in M199 without FCS and gonadot
ropins and in the presence of 10, 100, or 1,000 ng/ml bovine GH (NIH-G
H-B18). The COCs were incubated at 39 degrees C in a humidified atmosp
here with 5% CO2 in air and nuclear stage was assessed after 2, 4, 8,
16, 22, and 24 hr of incubation using DAPI staining. To assess the eff
ect of GH on developmental capacity of the oocytes, COCs were incubate
d in the presence of GH for 22 hr, followed by IVF and in vitro embryo
culture. Cultures without GH served as controls. For subsequent devel
opment, the embryos were cultured in M199 supplemented with 10% FCS on
a monolayer of BRL cells. Embryos were scored morphologically and the
efficiency of the culture system was evaluated as (1) the percentage
of cleaved embryos 4 days after IVF, (2) the percentage of blastocysts
on day 9 expressed on the basis of the number of oocytes at the onset
of culture, and (3) the percentage of hatched blastocysts on day 11 e
xpressed on the basis of the total number of blastocysts present at da
y 9. GH (100 and 1,000 ng/ml) significantly accelerated nuclear matura
tion (P <0.001). At 4 and 8 h the percentage of oocytes in GV stage af
ter GH treatment (54% and 19%) was significantly lower than the contro
l (64% and 41%). Similarly at 16 and 22 h the percentage of oocytes in
MII stage was significantly higher in the GH-treated group; (58% and
77%) and (46% and 62%) for GH and control respectively. The number of
oocytes in MII beyond 22 hr of culture did not differ; 100 and 1,000 n
g/ml GH induced significant cumulus expansion (P <0.05), which was not
observed in the absence of GH. Addition of 100 and 1,000 ng/ml GH dur
ing maturation significantly (P <0.01) enhanced subsequent cleavage ra
te from (64% and 67%) in control to (75% and 81%) in GH-treated group;
embryonic development in terms of day 9 blastocyst formation was also
significantly increased in the presence of GH (29% and 34%) compared
to the control (18% and 24%). The hatchability of the blastocysts was
not influenced by GH. From the present data, it can be concluded that
GH present during IVM has a beneficial effect on subsequent developmen
t. (C) 1996 Wiley-Liss, Inc.